The leukapheresis market in Europe is expected to grow from US$ 22.55 million in 2021 to US$ 39.26 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.
Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Russia, Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is driving the growth of the market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe leukapheresis market. The Europe leukapheresis market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Leukapheresis Market Segmentation
Europe Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
Europe Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
Europe Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
Europe Leukapheresis Market – By Country
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Europe Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Leukapheresis Market – By Product Type
1.3.2 Europe Leukapheresis Market – By Application
1.3.3 Europe Leukapheresis Market – By End User
1.3.4 Europe Leukapheresis Market – By Country
2. Europe Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Leukapheresis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. Europe Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Elevating Number of Voluntary Blood Donors
5.1.2 Growing Incidence of Hematologic Diseases
5.1.3 Scaling Elderly Population
5.2 Key Market Restraints
5.2.1 Heavy Cost of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Boosting Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Advancements in Therapeutic Apheresis
5.5 Impact Analysis
6. Europe Leukapheresis – Market Analysis
6.1 Europe Leukapheresis Market Revenue Forecast and Analysis
7. Europe Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. Europe Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 Europe Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. Europe Leukapheresis Market Analysis – by End-User
9.1 Overview
9.2 Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. Europe Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.2.1.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.2 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.3 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)
10.1.1.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)
10.1.1.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. Europe Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment Of COVID-19 Pandemic
12. Europe Leukapheresis Market – Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 6. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)
Table 10. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 14. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)
Table 15. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 18. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 19. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments Done by Companies
Table 26. Inorganic Developments Done by Companies
Table 27. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. Europe Leukapheresis Market Segmentation
Figure 2. Europe Leukapheresis Market Segmentation, By country
Figure 3. Europe Leukapheresis Market Overview
Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe Leukapheresis Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Europe Leukapheresis market impact analysis of driver and restraints
Figure 9. Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)
Figure 10. Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Europe Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)
Figure 25. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in European Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Leukapheresis Market
Nov 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Nov 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Nov 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Nov 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)